Buy 2 and save 9.55 USD / -22%
Otrivin Cold is used to treat colds of various types.
Otrivin Schnupfen is intended for use in the nose, where it constricts the blood vessels and thereby reduces swelling of the mucous membrane in the nose and in the adjacent area of the throat. This allows you to breathe more freely through your nose when you have a cold. The effect sets in within minutes and lasts for several hours. Otrivin Schnupfen contains additives (sorbitol solution and methylhydroxypropyl cellulose) that are intended to prevent the nasal mucosa from drying out.
Otrivin Schnupfen must not be used for longer than 1 week, since prolonged use can lead to permanent damage to the mucous membranes («rhinitis medicamentosa»).
Swissmedic-approved patient information
Otrivin Schnupfen GSK Consumer Healthcare Schweiz AGOtrivin Schnupfen is used to treat different types of colds kind used.
Otrivin Schnupfen is intended for use in the nose, where it constricts the blood vessels and thereby reduces swelling of the mucous membrane in the nose and in the adjacent area of the throat. This allows you to breathe more freely through your nose when you have a cold. The effect sets in within minutes and lasts for several hours. Otrivin Schnupfen contains additives (sorbitol solution and methylhydroxypropyl cellulose) that are intended to prevent the nasal mucosa from drying out.
Otrivin Schnupfen must not be used for longer than 1 week, since prolonged use can lead to permanent damage to the mucous membranes («rhinitis medicamentosa»).
After transnasal surgery (surgical interventions in the nose area during which the meninges were exposed), Otrivin Schnupfen can be used like other decongestants , are not applied.
Otrivin Schnupfen must not be used with:
When using Otrivin cold, sleep and visual disturbances or dizziness can occur appear as signs of increased sensitivity. Please contact your doctor
In the following cases, Otrivin Schnupfen should be used with caution and only after consultation with the doctor/pharmacist:
If you are taking or have taken within the last 14 days MAO inhibitors (medicines for depression). you should not use Otrivin Schnupfen.
If you are taking certain mood-enhancing medicines (tri- or tetracyclic antidepressants) or anti-Parkinson medicines (levodopa), you should also not use this medicine.
Otrivin Schnupfen must not be used for longer than 1 week, since prolonged use can trigger medication-related swelling of the nasal mucosa (rhinitis medicamentosa or rhinitis atrophicans), the symptoms of which are very similar to a cold.
Otrivin Schnupfen 0.05% should not be used in children under the age of 1 year. For children between 1 and 2 years of age, use only as prescribed by a doctor. Use in children from 2 to 11 years under adult supervision.
Otrivin Schnupfen 0.1% should not be used in children under 12 years of age.
Otrivin Schnupfen should not get in your mouth or eyes.
The recommended dosage should not be exceeded, especially in children and elderly patients.
Tell your doctor, pharmacist or druggist if you
Otrivin Schnupfen should not be used during pregnancy. During breastfeeding, Otrivin Schnupfen should only be used on medical advice.
Ask your doctor or pharmacist before using any medicine.
Unless otherwise prescribed by the doctor, the following dosage recommendations apply:
Children between 2-11 years: only use under adult supervision.
Usually 1-2 drops of the 0.05% solution or 1 spray with the dosing spray 0.05% in each nostril is sufficient 1 to 2 times a day, whereby 3 applications per day may not be exceeded.
Children between 1-2 years: Use only as prescribed by a doctor.
Children under 1 year: The preparation should not be used.
1 spray in each Nose hole. Repeat if necessary, not exceeding 3 applications per day.
Only for adults and adolescents aged 12 and over.
2-3 drops of the 0.1% solution or one spray with the nebulizer 0.1% in each nostril. Repeat if necessary, 3-4 applications per day should not be exceeded.
The last application of the day should preferably be just before bedtime.
Before use, the nose should be thoroughly cleaned (blow the nose).
Bend your head back slightly. Place the drops in each nostril and tilt your head back for a few moments to allow the drops to distribute.
Clean and dry the dropper before screwing it back onto the bottle.
Do not cut away the spray attachment.
The metering spray is ready for the first pump before use.
2.
Before use, the nose should be thoroughly cleaned (blow the nose).
Remove the protective cap.
Before the first use, press the pump 4 times. Be careful not to get spray in eyes or mouth.
The dosing spray is ready to use for all other applications. If the spray mist does not flow out completely after the pumping process, e.g. after an interruption in use, the pump must be operated 4 times again.
Hold the bottle upright with your thumb on the bottom and the spray head between two fingers. (Fig. 2).
3.
The dosing spray should only be used by one person, to prevent any spread of infection.
Before use, the nose should be thoroughly cleaned (blow the nose).
Insert the spray opening into the nostril and squeeze the side of the spray container firmly once. Pull back the spray orifice before releasing the pressure. An optimal distribution of the spray mist is achieved by gently inhaling through the nose during the spraying process.
Put the protective cap back on after use.
Otrivin Schupf should not be used for longer than 1 week.
If you use more Otrivin Schnupfen than you should, please inform your doctor immediately. Poisoning can occur from significant overdose or from accidental ingestion of the drug.
Stick to the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
Stop using Otrivin Schnupfen and seek medical help straight away if you or your child notice any of the symptoms below ; it could be an allergic reaction:
Dryness and irritation of the Nasal mucosa, nausea, headache and local burning sensation.
Allergic reactions (skin rash, itching), temporary blurred vision, irregular or accelerated palpitations, drug-related caused swelling of the nasal mucosa (rhinitis medicamentosa).
If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist.
The medicinal product may only be used up to the date marked ‹EXP› on the container.
Store at 15-30°C.
Keep out of the reach of children.
Your doctor, pharmacist or druggist can provide you with further information. These people have the detailed information for specialists.
Nasal drops 0.05% (children) contain xylometazoline hydrochloride 0.5 mg/ml; 1 drop contains 0.0125 mg xylometazoline hydrochloride.
Nasal drops 0.1% (adults) contain xylometazoline hydrochloride 1 mg/ml; 1 drop contains 0.025 mg xylometazoline hydrochloride.
Measuring spray 0.05% (children) contains xylometazoline hydrochloride 0.5 mg/ml; 1 spray (= 0.07 ml) contains 0.035 mg xylometazoline hydrochloride.
Measuring spray 0.1% (adults) contains xylometazoline hydrochloride 1 mg/ml; 1 spray (= 0.14 ml) contains 0.14 mg xylometazoline hydrochloride.
Nebulizer contains xylometazoline hydrochloride 1 mg/ml.
Sodium hydrogen phosphate, sodium dihydrogen phosphate, sodium edetate, sodium chloride, sorbitol, methylhydroxypropyl cellulose, water; as a preservative: benzalkonium chloride.
44939, 24926, 24959 (Swissmedic).
In pharmacies and drugstores without a doctor's prescription:
Dosing spray 0.1%: 10 ml
Nebulizer 0.1%: 10ml
Nasal drops 0.1%: 10 ml
Nasal drops 0.05%: 10 ml
Dosing spray 0.05%: 10 ml
GSK Consumer Healthcare Schweiz AG, Risch
This leaflet was last checked by the medicines authority (Swissmedic) in October 2019.